DUPHAT 2018 highlights ‘counterfeit pharmaceuticals in the Middle East’ on the 2 nd day


Counterfeit medicines seize 10% of the global drug market, according to the World Health Organization

Dubai, United Arab Emirates, 28 February 2018: The Dubai International Pharmaceutical and Technology Conference and Exhibition – DUPHAT 2018 continued for the second consecutive day at the Dubai International Convention and Exhibition Center and was attended by specialists, pharmaceutical professionals, industry experts and suppliers interested in the latest developments in the pharmaceutical sector from the region and around the world.

With the aim of encouraging student pharmacists in the UAE and around the world to adopt best practices and explore new approaches, DUPHAT 2018 has organized a number of scientific activities, parallel to the conference. This year, nearly 500 students representing various schools, colleges and universities in the UAE and abroad were offered a unique opportunity to participate in poster presentations and research paper presentations covering many key trending topics in the pharmaceutical world.



On the second day, DUPHAT 2018 highlighted many important topics in pharmacy, including Response to Prescription Medication Abuse – Strengthening Pharmacovigilance, Prescriptions for Improving Medication Use: Can the Promise of Technology Deliver? ‘Counterfeit in the Pharmaceutical Market’ and other important scientific topics.

Professor Robert Sindelar, Former Dean of the Faculty of Pharmaceutical Sciences, The University of British Columbia, Canada, said, “At DUPHAT, I intend to stress the importance of pharmacists actively engaging with their patients related to the exciting new biotechnologies that are changing the way medical care will be delivered in the future.  The human microbiome, genome editing tools such as CRISPR, the use of “big data” to continuously learn as a health care system, and cellular immunotherapy are all enabling biotechnologies that will impact the quality and precision of personalized health care delivery.  The pharmacist in both ambulatory care and institutional care must learn about these new technologies and explore ways they can assure improved patient outcomes for those patients treated by these biotechnologies.”

“DUPHAT 2018 is a great venue to explore these topics and have this discussion as it is the premier pharmacy and pharmaceutical sciences meeting in the Middle East and Northern Africa and one of the best attended conferences in the world.”  

According to the WHO, the Middle East, including the UAE is facing a significant challenge in terms of the proliferation of counterfeit drugs and the illegal re-importation of medicines. WHO studies suggest that counterfeit drugs had captured nearly 10 per cent of the global medicine market.

Running parallel to the conference, the DUPHAT exhibition, featured a host of new technologies, while industry professionals in the pharmaceutical sector were acquainted with the latest tools and techniques provided by 650 international pharmaceutical companies from 75 countries around the world.

DUPHAT is organized yearly by INDEX Conferences and Exhibitions Organisation Est. – member of INDEX Holding, and the conference is accredited by Dubai Health Authority, and The Society of Hospital Pharmacists, Australia.

**Please note, Thumbay Group, Gulf Medical University, and HEALTH magazine are not liable nor responsible for the facts, figures, and overall content of the press releases on our portal.

Related Articles